Aura Reshapes Leadership Around Ocular Oncology

Company: Aura Biosciences · Event Type: Leadership Change · Product/Asset: Susan Abu-Absi · Subject: Leadership · Event Date: August 11, 2026 Summary Aura Biosciences appointed Susan Abu-Absi chief operating officer effective August 10, added Erica Kratz as chief regulatory and quality officer and Julie Person…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Astellas / AviadoBio – Gene Therapy Program Sustained via Nonprofit Funding
Samsung Biologics Moves Into Peptide Manufacturing
Boulevard Bio Launches with $65 Million
GSK – $1B SiranBio Oligo Deal